Semaglutide is Novo Nordisk's GLP-1 drug, labeled Wegovy for long-term weight management and Ozempic for type 2 diabetes.
Ozempic, Wegovy and Medicare in Boca Raton
Close to one Boca Raton resident in four has passed 65 [3], and 13.7% of Palm Beach County adults carry a diabetes diagnosis [5]. Those numbers collide at the pharmacy. Ozempic is a type 2 diabetes drug without a weight-loss approval [7]. A Part D member who qualifies for the Medicare GLP-1 Bridge pays $50 a month for Wegovy pens or tablets, yet the Bridge excludes Ozempic [4] [8].
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Boca Raton, from $300 a month.
Paid placement: a practice bought this labeled box. It is not our pick.
Bridge coverage by product
| Product | Monthly price | Covered by Medicare Bridge? | Source |
|---|---|---|---|
| Wegovy pill (1.5 to 25 mg) | $149 to $299 | Yes | [1] |
| Wegovy pen (0.25 to 2.4 mg) | $349 | Yes | [1] |
| Ozempic pen (0.25 to 1 mg) | $349 | No | [2] |
| Ozempic pen (2 mg) | $499 | No | [2] |
The $199 offer ends December 31
A first-time self-pay buyer gets the 0.25 mg and 0.5 mg pens of Wegovy or Ozempic at $199 for each of two fills, until December 31, 2026 [1] [2]. Standard doses then cost $349. Against Boca Raton's $106,273 median household income [3], twelve months of Wegovy pens at $349 total $4,188.
From prescription to pickup
Register for Novo's offer, then have the prescriber send the order to NovoCare Pharmacy, or take the offer to a local pharmacy [1]. The Florida Board of Medicine licenses prescribers [9]. Clinic-made semaglutide lacks FDA approval and skips FDA review for safety, effectiveness or quality [10]; read compounded semaglutide. Also in South Florida: Fort Lauderdale, Miami, plus Tampa.
Trial snapshot
Two numbers from STEP 1 sum it up: a 14.9% average weight drop over 68 weeks on 2.4 mg, and 4.5% of that group quitting over stomach side effects (0.8% on placebo) [11]. Regain after stopping and the full data sit on semaglutide results [12]; prices are on Wegovy cost and the semaglutide guide.
Safety before you start
Both labels list acute pancreatitis: abdominal pain that is intense and will not settle needs prompt care [13] [7]. Because of a rodent thyroid C-cell tumor boxed warning, semaglutide is ruled out with medullary thyroid carcinoma or MEN 2 in you or your family. Insulin or sulfonylureas raise the chance of lows, a real issue for many people with diabetes. Swelling or breathing trouble needs help right away. Wegovy should be stopped once a pregnancy is recognized. Emergencies: 911.
Questions people ask
Can Boca Raton seniors get Ozempic through the Medicare GLP-1 Bridge?
No. CMS excludes Ozempic; the Bridge pays for Wegovy, Foundayo and the Zepbound KwikPen at $50 a month for eligible Part D members [4].
What is the Boca Raton cash price for Wegovy?
On Oct 17, 2026, NovoCare listed the pen at $349 a month and the tablets at $149 to $299 [1].
How much of Boca Raton is 65 or older?
Census QuickFacts puts the city's 65-plus share at 24.6%, close to one resident in four [3].
What is the diabetes rate in Palm Beach County?
13.7% of adults had diagnosed diabetes in 2023, per CDC PLACES county estimates [5].
Does Florida Medicaid cover semaglutide for weight loss?
No. Florida was not on KFF's January 2026 list of Medicaid programs paying for GLP-1s for obesity [6].
Who licenses Boca Raton prescribers?
The Florida Board of Medicine, part of the Florida Department of Health [9].
Sources
13 cited
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Ozempic self-pay pricing, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- QuickFacts: Boca Raton city, Florida. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, accessed 2026-10-17.
- PLACES data, county, 2025 release: Palm Beach County, FL. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- Ozempic label. DailyMed, National Library of Medicine, May 2026.
- Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), accessed 2026-10-17.
- Florida Board of Medicine. Florida Department of Health, accessed 2026-10-17.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine (PubMed), 2021.
- Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension). Diabetes, Obesity and Metabolism (PubMed), 2022.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.